Teladoc Health Inc (NYSE:TDOC) Insider Lewis Levy Sells 2,700 Shares

Share on StockTwits

Teladoc Health Inc (NYSE:TDOC) insider Lewis Levy sold 2,700 shares of the firm’s stock in a transaction dated Wednesday, July 10th. The shares were sold at an average price of $70.00, for a total value of $189,000.00. Following the sale, the insider now owns 6,080 shares of the company’s stock, valued at $425,600. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Lewis Levy also recently made the following trade(s):

  • On Monday, July 1st, Lewis Levy sold 1,350 shares of Teladoc Health stock. The shares were sold at an average price of $67.95, for a total value of $91,732.50.
  • On Monday, June 17th, Lewis Levy sold 675 shares of Teladoc Health stock. The shares were sold at an average price of $60.00, for a total value of $40,500.00.
  • On Monday, June 3rd, Lewis Levy sold 675 shares of Teladoc Health stock. The shares were sold at an average price of $58.00, for a total value of $39,150.00.
  • On Wednesday, May 1st, Lewis Levy sold 2,025 shares of Teladoc Health stock. The shares were sold at an average price of $60.00, for a total value of $121,500.00.

Shares of TDOC stock opened at $70.62 on Friday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 7.54 and a current ratio of 7.54. The company has a 50 day moving average of $61.87. Teladoc Health Inc has a 52 week low of $42.08 and a 52 week high of $89.05. The firm has a market capitalization of $5.06 billion, a P/E ratio of -49.04 and a beta of 1.30.

Teladoc Health (NYSE:TDOC) last issued its earnings results on Tuesday, April 30th. The health services provider reported ($0.43) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.44) by $0.01. Teladoc Health had a negative return on equity of 10.86% and a negative net margin of 22.63%. The company had revenue of $128.57 million during the quarter, compared to the consensus estimate of $127.99 million. During the same period in the previous year, the firm posted ($0.39) earnings per share. Teladoc Health’s quarterly revenue was up 43.4% compared to the same quarter last year. As a group, analysts anticipate that Teladoc Health Inc will post -1.53 earnings per share for the current fiscal year.

A number of hedge funds have recently modified their holdings of the business. LPL Financial LLC lifted its holdings in Teladoc Health by 51.9% in the 4th quarter. LPL Financial LLC now owns 19,675 shares of the health services provider’s stock worth $975,000 after purchasing an additional 6,721 shares in the last quarter. PNC Financial Services Group Inc. lifted its holdings in Teladoc Health by 24.4% in the 4th quarter. PNC Financial Services Group Inc. now owns 5,117 shares of the health services provider’s stock worth $255,000 after purchasing an additional 1,005 shares in the last quarter. California Public Employees Retirement System lifted its holdings in Teladoc Health by 51.4% in the 4th quarter. California Public Employees Retirement System now owns 109,824 shares of the health services provider’s stock worth $5,444,000 after purchasing an additional 37,300 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in Teladoc Health by 86.5% in the 4th quarter. Bank of New York Mellon Corp now owns 980,577 shares of the health services provider’s stock worth $48,605,000 after purchasing an additional 454,702 shares in the last quarter. Finally, Northern Trust Corp lifted its holdings in Teladoc Health by 2.2% in the 4th quarter. Northern Trust Corp now owns 918,868 shares of the health services provider’s stock worth $45,548,000 after purchasing an additional 19,943 shares in the last quarter.

A number of research firms recently commented on TDOC. Cantor Fitzgerald reiterated a “buy” rating and issued a $143.00 price target on shares of Eli Lilly And Co in a research note on Tuesday, April 30th. Stephens reiterated a “neutral” rating on shares of First Horizon National in a research note on Tuesday, April 16th. ValuEngine upgraded Zogenix from a “buy” rating to a “strong-buy” rating in a research note on Thursday, June 27th. Craig Hallum lifted their price target on 1-800-Flowers.Com from $26.00 to $20.00 and gave the stock a “buy” rating in a research note on Wednesday, May 1st. Finally, Bank of America set a $10.00 price target on HEXO and gave the stock a “buy” rating in a research note on Thursday, June 13th. Three analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Teladoc Health has a consensus rating of “Buy” and an average target price of $82.68.

About Teladoc Health

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

See Also: What is the significance of a dead cat bounce?

Insider Buying and Selling by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Insider Selling: NetGear, Inc.  SVP Sells 2,234 Shares of Stock
Insider Selling: NetGear, Inc. SVP Sells 2,234 Shares of Stock
Dyadic International, Inc  VP Sells $58,700.00 in Stock
Dyadic International, Inc VP Sells $58,700.00 in Stock
Insider Buying: Pathfinder Bancorp Inc  Insider Acquires $65,780.00 in Stock
Insider Buying: Pathfinder Bancorp Inc Insider Acquires $65,780.00 in Stock
Francesca’s Holdings Corp  Major Shareholder Purchases $70,905.00 in Stock
Francesca’s Holdings Corp Major Shareholder Purchases $70,905.00 in Stock
GW Pharmaceuticals PLC-  Insider Sells $71,638.56 in Stock
GW Pharmaceuticals PLC- Insider Sells $71,638.56 in Stock
Insider Selling: Ciena Co.  SVP Sells $84,000.00 in Stock
Insider Selling: Ciena Co. SVP Sells $84,000.00 in Stock


© 2006-2019 Ticker Report